Mio Yamamoto

Targeting Activating Transcription Factor 3 by Galectin-9 Induces Apoptosis and Overcomes Various Types of Treatment Resistance in Chronic Myelogenous Leukemia

Junya Kuroda, Mio Yamamoto, Hisao Nagoshi et al. · Molecular Cancer Research · 2010 · 76 citations

Mixed-phenotype Acute Leukemia, Apoptosis, Immunology +19

Cyclosporine A for Chemotherapy-Resistant Subcutaneous Panniculitis-Like T Cell Lymphoma with Hemophagocytic Syndrome

Shinsuke Mizutani, Junya Kuroda, Yuji Shimura et al. · Acta Haematologica · 2011 · 40 citations

Immunodeficiencies, Immunology, Pathology +17

Bcl-2 is a better therapeutic target than c-Myc, but attacking both could be a more effective treatment strategy for B-cell lymphoma with concurrent Bcl-2 and c-Myc overexpression

Nana Sasaki, Junya Kuroda, Hisao Nagoshi et al. · Experimental Hematology · 2011 · 33 citations · Full text

B-cell Lymphoma, Lymphoid Neoplasia, Concurrent Bcl-2 +9

Orthostatic Blood Pressure Changes and Subclinical Markers of Atherosclerosis

Maasa Takahashi, Nobuyuki Miyai, Shiori Nagano et al. · American Journal of Hypertension · 2015 · 29 citations · Full text

Expression of Master Regulators of Helper T-Cell Differentiation in Peripheral T-Cell Lymphoma, Not Otherwise Specified, by Immunohistochemical Analysis

Yosuke Matsumoto, Shigeo Horiike, Muneo Ohshiro et al. · American Journal of Clinical Pathology · 2010 · 22 citations · Full text

T-regulatory Cell, Immunology, Immune Regulation +17